1. Home
  2. RPGL vs GOVX Comparison

RPGL vs GOVX Comparison

Compare RPGL & GOVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

RPGL

Republic Power Group Limited Class A Ordinary Shares

N/A

Current Price

$0.50

Market Cap

3.6M

Sector

Technology

ML Signal

N/A

Logo GeoVax Labs Inc.

GOVX

GeoVax Labs Inc.

HOLD

Current Price

$1.42

Market Cap

4.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RPGL
GOVX
Founded
2015
2001
Country
Singapore
United States
Employees
8
17
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.6M
4.0M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
RPGL
GOVX
Price
$0.50
$1.42
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$200.00
AVG Volume (30 Days)
1.1M
61.9K
Earning Date
05-16-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$21.40
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.23
$0.12
52 Week High
$8.44
$4.40

Technical Indicators

Market Signals
Indicator
RPGL
GOVX
Relative Strength Index (RSI) 42.48 35.83
Support Level $0.30 $1.32
Resistance Level $0.60 $1.39
Average True Range (ATR) 0.14 0.14
MACD -0.08 -0.02
Stochastic Oscillator 2.20 8.96

Price Performance

Historical Comparison
RPGL
GOVX

About RPGL Republic Power Group Limited Class A Ordinary Shares

Republic Power Group Ltd is a provider of customized ERP software solutions, consulting and technical support services, and peripheral hardware to corporate clients and government agencies, including airports, cruise terminals, and technology, trading, and logistics companies. The Company operates from Singapore and has historically served clients in Singapore and Malaysia, offering ERP systems with functions such as accounting, procurement, workflow automation, real-time monitoring, and capabilities including planning, surveillance, and threat detection. The Company leverages artificial intelligence and modular algorithms to address complex operational requirements and integrates sensors, controls, and other hardware to enable IoT connectivity with autonomous or semiautonomous outcomes.

About GOVX GeoVax Labs Inc.

Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. GeoVax's product pipeline includes ongoing human clinical trials for a next-generation COVID-19 vaccine and a gene-directed therapy against head and neck cancers. Additional research and development programs include preventive vaccines against Monkeypox (MPox), hemorrhagic fever viruses (Ebola Zaire, Ebola Sudan, Marburg, and Lassa), and Zika virus, as well as immunotherapies for multiple solid tumors. The Company's key clinical program is GEO-CM04S1, a next-generation COVID-19 vaccine.

Share on Social Networks: